/
Hum Gene Ther
Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma
- A. Buchner
- H. Pohla
- G. Willimsky
- B. Frankenberger
- R. Frank
- A. Baur-Melnyk
- M. Siebels
- C.G. Stief
- A. Hofstetter
- J. Kopp
- A. Pezzutto
- T. Blankenstein
- R. Oberneder
- D.J. Schendel